228 related articles for article (PubMed ID: 11083738)
1. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure.
Krum H; Ninio D; MacDonald P
Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure.
Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ
J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817
[TBL] [Abstract][Full Text] [Related]
3. Observational cohort study to monitor the use and safety of carvedilol in the treatment of heart failure in clinical practice in England--1st interim report.
Acharya NV; Wilton LV; Shakir SA
Int J Clin Pharmacol Ther; 2005 Jan; 43(1):1-6. PubMed ID: 15704607
[TBL] [Abstract][Full Text] [Related]
4. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study.
Krum H; Hill J; Fruhwald F; Sharpe C; Abraham G; Zhu JR; Poy C; Kragten JA
Eur J Heart Fail; 2006 May; 8(3):302-7. PubMed ID: 16198627
[TBL] [Abstract][Full Text] [Related]
6. The impact of baseline HR and BP on the tolerability of carvedilol in the elderly: the COLA (Carvedilol Open Label Assessment) II Study.
Macdonald PS; Hill J; Krum H;
Am J Cardiovasc Drugs; 2006; 6(6):401-5. PubMed ID: 17192130
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
[TBL] [Abstract][Full Text] [Related]
8. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
[TBL] [Abstract][Full Text] [Related]
10. Use and risk management of carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study.
Aurich-Barrera B; Wilton LV; Shakir SA
Drug Saf; 2009; 32(1):43-54. PubMed ID: 19132804
[TBL] [Abstract][Full Text] [Related]
11. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
[TBL] [Abstract][Full Text] [Related]
12. [Tolerability and clinical effects of carvedilol in patients over 70 years of age with chronic heart failure due to left ventricular dysfunction].
Cioffi G; Stefenelli C
Ital Heart J Suppl; 2001 Dec; 2(12):1319-29. PubMed ID: 11838355
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
Kotlyar E; Keogh AM; Macdonald PS; Arnold RH; McCaffrey DJ; Glanville AR
J Heart Lung Transplant; 2002 Dec; 21(12):1290-5. PubMed ID: 12490274
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol improves functional class in patients with severe left ventricular dysfunction referred for heart transplantation.
Pamboukian SV; Aminbakhsh A; Thompson CR; Amin H; Mortimer S; D'yachkova Y; Ignaszweski AP
Clin Transplant; 1999 Oct; 13(5):426-31. PubMed ID: 10515224
[TBL] [Abstract][Full Text] [Related]
16. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
[TBL] [Abstract][Full Text] [Related]
17. [Long-term outcome and tolerability of carvedilol therapy in Japanese patients with chronic heart failure].
Kawashiro N; Matsuda N; Endo Y; Uchida Y; Kasanuki H
J Cardiol; 2006 May; 47(5):229-37. PubMed ID: 16764329
[TBL] [Abstract][Full Text] [Related]
18. Heart failure in a district general hospital: are target doses of beta-blockers realistic?
Mehta PA; McDonagh S; Poole-Wilson PA; Grocott-Mason R; Dubrey SW
QJM; 2004 Mar; 97(3):133-9. PubMed ID: 14976270
[TBL] [Abstract][Full Text] [Related]
19. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
[TBL] [Abstract][Full Text] [Related]
20. Predictors of stable outcome in treating chronic heart failure patients with carvedilol.
Ho WJ; Tsay PK; Chu PH; Chang CJ; Kuo CT; Chen WJ
Jpn Heart J; 2004 Sep; 45(5):823-32. PubMed ID: 15557723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
